Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 25, 2003

View Archived Issues

ANUP peptides reduce tumor growth and inhibit angiogenesis

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Callisto

Medivir and Hengrui to develop protease inhibitor drugs for COPD

Xantryl advances for psoriasis

Tolerance of MEDI-522 in patients with advanced solid tumors

Synergistic antitumor effects described for CNTO-95 and paclitaxel

Trabectedin alone or in combination in the treatment of advanced solid tumors

Increased antitumor activity of pertuzumab combined with cytotoxic drugs in NSCLC models

Metastatic melanoma as a potential new indication for arsenic trioxide

Enzon enters collaborative development program with NIH for SS1P

PPD and Syrrx to develop orally delivered DP4 inhibitors

Therion evaluates Prostvac-VF in new phase II prostate cancer study

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Introgen Therapeutics

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Cortex

Oritavancin NDA filing delayed

Lilly Icos receives FDA approval for Cialis

Phase II MEND-CABG study cleared to commence in U.S. and Canada

Merck & Co. discontinues phase III program for MK-767

Phase I study of oral methylnaltrexone commences dosing

Zeria presents novel gastric antisecretory agents in a recent patent

New opioid analgesics prepared and tested by Nippon Chemiphar team

New muscarinic M3 antagonists and their use in urinary incontinence, COPD, IBS, etc.

Merck researchers identify new CB1 modulators for obesity and other uses

New FTase inhibitors in early development at Janssen

Antioxidants and their therapeutic use covered by Tanabe Seiyaku patent

Shionogi describes GM-CSF-like compounds with potential in cancer and neutropenia

Boehringer Ingelheim presents new muscarinic M3 antagonists

Antitumor activity of MLN-944 due to inhibition of DNA and RNA synthesis

New hypoxic cytotoxin shows promising in vitro and in vivo activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...